The Human Genome Project and Drug Discovery in Psychiatry: Identifying Novel Targets

SHELDON H. PRESKORN, MD, is Professor and Chairman, Department of Psychiatry, University of Kansas School of Medicine-Wichita, and Director, Psychiatric Research Institute, Wichita, Kansas. He has more than 20 years of drug development research experience at all levels (i.e., preclinical through Phase IV) and has been a principal investigator on over 150 clinical trials including every antidepressant marketed in the United States over the last decade.